凯赛生物
(688065)
| 流通市值：285.91亿 | | | 总市值：353.50亿 |
| 流通股本：5.83亿 | | | 总股本：7.21亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,637,141,251.89 | 4,634,914,162.16 | 4,987,762,122.15 | 5,390,218,174.98 |
| 应收票据及应收账款 | 419,078,736.59 | 394,289,051.99 | 362,646,530.52 | 306,119,845.4 |
| 其中：应收票据 | 105,550,077.81 | 88,809,104.17 | 70,956,361.63 | 62,863,954.28 |
| 应收账款 | 313,528,658.78 | 305,479,947.82 | 291,690,168.89 | 243,255,891.12 |
| 应收款项融资 | 73,009,084.35 | 103,015,041.82 | 68,692,539.13 | 79,402,948.02 |
| 预付款项 | 82,564,799.49 | 59,889,705.67 | 58,700,922.41 | 30,524,059.37 |
| 其他应收款合计 | 6,562,450.97 | 7,013,855.62 | 8,764,040.81 | 10,354,231.73 |
| 存货 | 1,273,811,937.54 | 1,328,845,099.57 | 1,374,593,313.28 | 1,466,355,603.97 |
| 其他流动资产 | 319,726,843.14 | 298,879,324.51 | 289,853,854.76 | 287,224,097.38 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,812,364,351.97 | 6,827,315,489.34 | 7,151,482,571.06 | 7,570,668,208.85 |
| 非流动资产: | | | | |
| 长期股权投资 | 137,716,005.08 | 138,915,947.52 | 141,067,497.91 | 142,732,325.97 |
| 固定资产 | 3,953,094,508.92 | 4,009,201,341.13 | 3,867,977,934.88 | 3,932,720,470.5 |
| 在建工程 | 5,782,495,722.36 | 5,641,889,073.62 | 5,673,666,796.24 | 5,443,065,405.95 |
| 无形资产 | 689,208,045.35 | 694,279,222.48 | 698,840,188.62 | 703,853,601.09 |
| 长期待摊费用 | 7,107,279.92 | 6,923,884.68 | 6,477,992.08 | 4,976,883.2 |
| 递延所得税资产 | 177,173,395.86 | 172,815,123.32 | 168,971,446.5 | 158,876,956.81 |
| 其他非流动资产 | 770,876,693.27 | 831,352,311.92 | 909,259,335.94 | 876,478,907.51 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 11,517,671,650.76 | 11,495,376,904.67 | 11,466,261,192.17 | 11,262,704,551.03 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 18,330,036,002.73 | 18,322,692,394.01 | 18,617,743,763.23 | 18,833,372,759.88 |
| 流动负债: | | | | |
| 短期借款 | 691,282,735.14 | 698,921,226.34 | 630,633,941.59 | 746,254,035.09 |
| 应付票据及应付账款 | 1,492,526,872.41 | 1,475,739,667.64 | 1,448,608,137.29 | 1,681,949,742.05 |
| 其中：应付票据 | - | - | 30,000,000 | 30,000,000 |
| 应付账款 | 1,492,526,872.41 | 1,475,739,667.64 | 1,418,608,137.29 | 1,651,949,742.05 |
| 预收款项 | 4,030,939.45 | 5,542,541.74 | 1,016,536.3 | 2,519,337.16 |
| 合同负债 | 26,550,628.45 | 12,873,464.1 | 27,937,855.41 | 10,477,981.74 |
| 应付职工薪酬 | 16,514,754.07 | 11,050,020.82 | 6,296,555.7 | 12,672,123.17 |
| 应交税费 | 34,038,786.47 | 25,095,095.57 | 61,062,848.22 | 65,467,715.01 |
| 其他应付款合计 | 70,959,925.46 | 188,797,528.03 | 119,840,489.81 | 102,701,219.66 |
| 应付股利 | 831,600 | 111,283,374.96 | 831,600 | 831,600 |
| 一年内到期的非流动负债 | 34,749,967.25 | 34,753,915.03 | 454,635,620.86 | 784,368,940.6 |
| 其他流动负债 | 3,451,581.7 | 1,673,550.33 | 3,631,921.2 | 3,341,581.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,374,106,190.4 | 2,454,447,009.6 | 2,753,663,906.38 | 3,409,752,675.79 |
| 非流动负债: | | | | |
| 长期借款 | 572,015,398.4 | 577,509,198.4 | 597,589,001.2 | 245,331,608.6 |
| 递延收益 | 394,730,163.78 | 400,146,752.7 | 402,590,722.12 | 405,178,272.77 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 966,745,562.18 | 977,655,951.1 | 1,000,179,723.32 | 650,509,881.37 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,340,851,752.58 | 3,432,102,960.7 | 3,753,843,629.7 | 4,060,262,557.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 583,378,039 | 583,378,039 | 583,378,039 | 583,378,039 |
| 资本公积 | 8,530,318,457.92 | 8,528,721,729.22 | 8,527,876,585.63 | 8,525,528,271.82 |
| 减:库存股 | 145,126,101.03 | 144,115,494.4 | 142,628,826.41 | 126,194,230.07 |
| 其他综合收益 | 3,868,949.34 | 859,073.78 | 1,576,156.89 | 3,652,110.71 |
| 专项储备 | 12,575,035.83 | 11,982,914.12 | 10,761,223.61 | 10,799,255.63 |
| 盈余公积 | 98,416,146.86 | 98,416,146.86 | 98,416,146.86 | 98,416,146.86 |
| 未分配利润 | 2,303,326,680.95 | 2,205,594,870.47 | 2,173,859,737.88 | 2,068,601,037.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,386,757,208.87 | 11,284,837,279.05 | 11,253,239,063.46 | 11,164,180,631.89 |
| 少数股东权益 | 3,602,427,041.28 | 3,605,752,154.26 | 3,610,661,070.07 | 3,608,929,570.83 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 14,989,184,250.15 | 14,890,589,433.31 | 14,863,900,133.53 | 14,773,110,202.72 |
| 负债和股东权益合计 | 18,330,036,002.73 | 18,322,692,394.01 | 18,617,743,763.23 | 18,833,372,759.88 |
| 公告日期 | 2024-10-31 | 2024-08-16 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |